News | October 05, 2009

Frost & Sullivan Names Viatronix Emerging Company of the Year

October 5, 2009 - The 2009 Frost & Sullivan European Medical Imaging Emerging Company of the Year Award in the radiology applications market is conferred on Viatronix for its innovative 3D computer imaging technologies in the diagnostic imaging space.

"Despite being a young company, Viatronix has shown dedication to both developing and distributing high-end, organ-specific 3D clinical solutions, while advancing its ability to address changing market trends," saidFrost & Sullivan Research Analyst Gideon Praveen Kumar. "The company has emerged as a leader in the 3D imaging market in Europe as a result of recent high profile partnerships and its active engagement with the medical community through participation in clinical trials and physician training programs."

Since its inception, the company has strived to offer efficient diagnostic solutions in areas such as colon cancer screening, cardiac analysis and vascular analysis. Through its innovative, cost- effective offerings that reduce read time, Viatronix applications optimize the utilization of CT scanners.

"Grasping the potential offered by the fast growing PACS market, the Company has added a robust PACS interface to its clinical applications, besides offering software-only solutions," says Kumar. "Viatronix has, therefore, not only tapped into the trend of offering advanced visualization technologies through PACS, but has also successfully kept itself at the forefront of developing market trends for end users to turn to high-end, organ-specific clinical solutions as opposed to general purpose 3D imaging."

In 2005, Viatronix entered into a partnership with Eastman Kodak Company (now known as Carestream), a global leader in advanced healthcare products. The company successfully integrated its V3D-Colon application into the CARESTREAM PACS System, allowing Viatronix to leverage the sales and marketing potential of Carestream to reach an extensive customer base.

Viatronix also entered into separate agreements with iCAD Inc., and Medicsight PLC regarding the integration of colon CAD. The Company has also signed an agreement with Visage Imaging Inc., for the distribution of it V3D-Colon platform.

"As the medical imaging world moves from a 2D arena to 3D arena, Viatronix's primary marketing efforts have been to sponsor and offer educational programs to radiologists," remarks Kumar. "Along with additional on-site training rendered to physicians, these educational programmes have made the technological barrier as simple as possible for physicians."

In Dec. 2003 in the landmark clinical trial published in the New England Journal of Medicine that put virtual colonoscopy on the world map and for the first time showed a high degree of sensitivity and specificity, the Viatronix V3D-Colon platform was the only platform used. Subsequent to the 2003 clinical trial, the Viatronix V3D-Colon product has been used in many clinical trials in Europe and the U.S. Viatronix V3D-Colon remains the only module on the market with a large number of clinical trials under its belt with more on their way.

The base 3D visualization workflow that has been developed by Viatronix is now being utilized into developing different organ-specific clinical applications in a cost-effective manner. The company is currently focused on the roll out of its V3D-Cardiac module which is expected to be another industry leading product.

"Viatronix enjoys a competitive edge by having similar workflows and a simple look and feel across all of its products," concludes Kumar. "Also, by providing software-only, organ-specific modules, Viatronix has gained an aggressive advantage over competitors who either require specific hardware for their applications and/or require the end user to purchase a base module before being able to acquire organ specific clinical applications."

The Frost & Sullivan Award for Emerging Company of the Year is presented to the company that has emerged as a significant participant within its industry. This company is perceived to have exhibited outstanding management, superior market growth, exceptional customer service and the ability to combine technology and successful strategic initiatives. This company has the exceptional know-how to take advantage of market changes through the execution of innovative strategies within the existing competitive landscape.

Frost & Sullivan Best Practices Awards recognize companies in a variety of regional and global markets for demonstrating outstanding achievement and superior performance in areas such as leadership, technological innovation, customer service, and strategic product development. Industry analysts compare market participants and measure performance through in-depth interviews, analysis, and extensive secondary research in order to identify best practices in the industry.

Related Content

Carestream dose management
Sponsored Content | Whitepapers | Advanced Visualization | August 17, 2017
It's critical for today's healthcare professionals to understand the balance between the risks and benefits of any X-...
Carestream Launches MR Brain Perfusion and Diffusion Modules for Vue PACS
Technology | Advanced Visualization | August 16, 2017
Carestream Health recently introduced new MR (magnetic resonance) Brain Perfusion and MR Brain Diffusion modules that...
CDN to Integrate Advanced Cardiac Imaging Tools From DiA Imaging Analysis
Technology | Advanced Visualization | August 10, 2017
August 10, 2017 — CDN recently announced a new partnership agreement with DiA Imaging Analysis Ltd., makers of next-g
GE Additive and Stryker Announce Additive Manufacturing Partnership
News | 3-D Printing | July 06, 2017
July 6, 2017 — GE Additive and Stryker have entered a partnership agreement to support Stryker’s growth in...
Philips Receives FDA 510(k) Clearance for IntelliSpace Portal 9.0
Technology | Advanced Visualization | June 29, 2017
Philips announced it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market...
Strain Imaging Improves Cardiac Surveillance of Certain Breast Cancer Patients
News | Cardio-oncology | May 03, 2017
Epsilon Imaging Inc. announced a research study using EchoInsight was presented at the American College of Cardiology (...
Fovia and Predible Health Combine XStream HDVR with Deep Learning to Fight Cancer
News | Advanced Visualization | April 25, 2017
Fovia Inc. and Predible Health announced a new collaboration to combine high-quality imaging performance and accuracy...
SyntheticMR Myelination Quantification Feature Receives CE Mark
News | Magnetic Resonance Imaging (MRI) | April 19, 2017
April 19, 2017 — REMyDI (Rapid Estimation of Myelin for Diagnostic Imaging), first introduced by SyntheticMR AB at th
3-D-printed Model of Stenotic Intracranial Artery Enables Vessel-Wall MRI Standardization
News | 3-D Printing | April 18, 2017
April 18, 2017 — A collaboration between stroke neurologists at the Medical University of South Carolina (MUSC) and b
3-D Prints Compare Effectiveness of Top Surgical Techniques for Repairing Heel Deformity
News | 3-D Printing | April 18, 2017
Using 3-D models of a patient’s foot, investigators at Cedars-Sinai have found that the three leading procedures for...
Overlay Init